3Eisele B,Lamy M,Thijs LG,et al. Antithrombin Ⅲ in patients with severe sepsis : a randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized,placebo-controlled,double-blind trial with antithrombin Ⅲ in severe sepsis[J]. Intensive Care Med, 1998,24(7 ) : 663-672.
4Opal S. New treatment in sepsis[J]. Biomed Prog, 1998,11 ( 1 ) : 52-56.
4Lin S D,Endo R,Kuroda H,et al.Plasma and urine levels of urinary trypsin inhibitor in patients with chronic liver diseases and hepatocellular carcinoma[J].J Gastroenterol Hepatol,2004,19(3):327-332.
5Bone R C,Balk R A,Cerra F B,et al.Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.The ACCP/SCCM Consensus Conference Committee.American College of Chest Physicians/Society of Critical Care Medicine[J].Chest,1992,101(6):1644-1655.
6SHI DELIN,RYUJINENDO,HIDEKATSUKURODA,KORYOKONDO,YOSHIAKIMIURA,YASUHIROTAKIKAWA,AKINOBUKATO,KAZUYUKISUZUKI.Plasma and urine levels of urinary trypsin inhibitor in patients with chronic liver diseases and hepatocellular carcinoma[J].Journal of Gastroenterology and Hepatology.2004(3)
